Brett Soloway - Mar 7, 2022 Form 4 Insider Report for Cushman & Wakefield plc (CWK)

Role
Executive VP General Counsel and Corporate Secretary
Signature
/s/ Brett Soloway
Stock symbol
CWK
Transactions as of
Mar 7, 2022
Transactions value $
$0
Form type
4
Date filed
3/9/2022, 05:46 PM
Previous filing
Mar 1, 2022
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CWK Ordinary Shares Options Exercise $0 +6.72K +4.28% $0.00 164K Mar 7, 2022 Direct F1
transaction CWK Ordinary Shares Award $0 +16K +9.75% $0.00 180K Mar 7, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CWK Restricted Stock Units Options Exercise $0 -6.72K -50% $0.00 6.72K Mar 7, 2022 Ordinary Shares 6.72K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion of previously awarded restricted stock units ("RSUs") into an equal number of ordinary shares, without the payment of any consideration, pursuant to the Amended & Restated Cushman & Wakefield plc 2018 Omnibus Management Share and Cash Incentive Plan (the "A&R Omnibus Plan").
F2 Represents vesting of ordinary shares earned in respect of performance-based restricted stock units ("PBRSUs") based on the achievement by the Issuer of certain performance targets for the 2019-2022 performance period pursuant to the A&R Omnibus Plan. The reporting person has elected to defer settlement of award until the earlier of January 2024 or termination under the Cushman & Wakefield plc Deferred Compensation Plan (the "Deferred Compensation Plan").
F3 RSUs were granted on March 7, 2019 and vest on the anniversary of the grant date in four (4) substantially equal installments on each of the first four (4) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date. The reporting person has elected to defer settlement of award until the earlier of January 2024 or termination under the Deferred Compensation Plan.

Remarks:

Executive VP General Counsel and Corporate Secretary